These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24725347)

  • 1. Oligomer-targeting with a conformational antibody fragment promotes toxicity in Aβ-expressing flies.
    Wacker J; Rönicke R; Westermann M; Wulff M; Reymann KG; Dobson CM; Horn U; Crowther DC; Luheshi LM; Fändrich M
    Acta Neuropathol Commun; 2014 Apr; 2():43. PubMed ID: 24725347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect.
    Liu YH; Bu XL; Liang CR; Wang YR; Zhang T; Jiao SS; Zeng F; Yao XQ; Zhou HD; Deng J; Wang YJ
    J Neuroinflammation; 2015 Aug; 12():153. PubMed ID: 26311039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment.
    Morgado I; Wieligmann K; Bereza M; Rönicke R; Meinhardt K; Annamalai K; Baumann M; Wacker J; Hortschansky P; Malešević M; Parthier C; Mawrin C; Schiene-Fischer C; Reymann KG; Stubbs MT; Balbach J; Görlach M; Horn U; Fändrich M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12503-8. PubMed ID: 22814377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of amyloid-beta glycine 33 in oligomerization, toxicity, and neuronal plasticity.
    Harmeier A; Wozny C; Rost BR; Munter LM; Hua H; Georgiev O; Beyermann M; Hildebrand PW; Weise C; Schaffner W; Schmitz D; Multhaup G
    J Neurosci; 2009 Jun; 29(23):7582-90. PubMed ID: 19515926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of β-Amyloid Toxicity In Vitro and In Vivo by Accelerated Aggregation.
    Yang A; Wang C; Song B; Zhang W; Guo Y; Yang R; Nie G; Yang Y; Wang C
    Neurosci Bull; 2017 Aug; 33(4):405-412. PubMed ID: 28555357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
    Lindhagen-Persson M; Brännström K; Vestling M; Steinitz M; Olofsson A
    PLoS One; 2010 Nov; 5(11):e13928. PubMed ID: 21085663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.
    Luheshi LM; Hoyer W; de Barros TP; van Dijk Härd I; Brorsson AC; Macao B; Persson C; Crowther DC; Lomas DA; Ståhl S; Dobson CM; Härd T
    PLoS Biol; 2010 Mar; 8(3):e1000334. PubMed ID: 20305716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
    Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
    J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?
    Klein WL; Krafft GA; Finch CE
    Trends Neurosci; 2001 Apr; 24(4):219-24. PubMed ID: 11250006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
    Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG
    J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression in drosophila of tandem amyloid β peptides provides insights into links between aggregation and neurotoxicity.
    Speretta E; Jahn TR; Tartaglia GG; Favrin G; Barros TP; Imarisio S; Lomas DA; Luheshi LM; Crowther DC; Dobson CM
    J Biol Chem; 2012 Jun; 287(24):20748-54. PubMed ID: 22461632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.
    Wang Y; Xia Z; Xu JR; Wang YX; Hou LN; Qiu Y; Chen HZ
    Neuropharmacology; 2012 Feb; 62(2):871-81. PubMed ID: 21958557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
    Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
    J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Aβ peptides attenuate Aβ42 toxicity in vivo.
    Moore BD; Martin J; de Mena L; Sanchez J; Cruz PE; Ceballos-Diaz C; Ladd TB; Ran Y; Levites Y; Kukar TL; Kurian JJ; McKenna R; Koo EH; Borchelt DR; Janus C; Rincon-Limas D; Fernandez-Funez P; Golde TE
    J Exp Med; 2018 Jan; 215(1):283-301. PubMed ID: 29208777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new β amyloid-derived peptide Aβ1-6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity.
    Diomede L; Romeo M; Cagnotto A; Rossi A; Beeg M; Stravalaci M; Tagliavini F; Di Fede G; Gobbi M; Salmona M
    Neurobiol Dis; 2016 Apr; 88():75-84. PubMed ID: 26792398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane.
    Zhang L; Trushin S; Christensen TA; Tripathi U; Hong C; Geroux RE; Howell KG; Poduslo JF; Trushina E
    Neurobiol Dis; 2018 Jun; 114():1-16. PubMed ID: 29477640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.